+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insulin Delivery Devices Market Size, Outlook and Growth Opportunities, 2019- 2025

  • ID: 4859083
  • Report
  • November 2019
  • Region: Global
  • OG Analysis
UP TO OFF until Jul 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd.
  • Eli Lilly
  • F. Hoffmann-La Roche Ltd.
  • Insulet
Global Insulin Delivery Devices Market Size, Outlook and Growth Opportunities to 2025: By Product (Insulin syringes, Insulin pens, Insulin pumps, and Insulin injectors), By End Use (Hospital, Homecare, and Others) and By Region

The 'Insulin Delivery Devices market outlook to 2025' report includes the latest predictions of the global Insulin Delivery Devices market along with geography, therapy area, and applications. The report specifically focuses on different types of Insulin Delivery Devices with special attention to their emergence over the forecast period to 2025.

The research report provides objective measures to tap into future opportunities that will be available over the next six-years. It also highlights key areas to watch over the future along with detailed insights into drivers and challenges across different Insulin Delivery Devices applications and products.

The Insulin Delivery Devices market report aggregates the current market size based on volume and average price data. It also includes a six-year outlook to 2025 based on anticipated growth rates for each sub-segment and industry as a whole.

The base case outlook in the next six-years for different types of Insulin Delivery Devices, across different verticals and countries, is provided. It additionally examines the key dynamics around companies, markets, along with key trends, drivers and challenges facing the Insulin Delivery Devices worldwide.

The report covers a broad region from the Asia Pacific, North America, Europe, Latin America, and Middle East Africa from 2018 to 2025. 12 countries across these regions are analyzed independently in the Insulin Delivery Devices report. Impact of domestic market conditions, price variations, competition, government policies, healthcare spending, technological and local market conditions are assessed for country-level forecasts.

Global spending on healthcare continues to increase significantly with the aging population, increased access to treatment and ongoing advancements in technology. This provides strong support for Insulin Delivery Devices market growth in the medium to long term future. While growth will remain steady in the developed markets, Asian and other emerging markets will be key for Insulin Delivery Devices market growth from 2019 to 2025.

To address the expanding need for advanced Insulin Delivery Devices products, companies are rapidly embracing the new market dynamics, primarily focusing on new launches, specifically to suit local and regional demand patterns. Accordingly, detailed discussion about broader implications of key strategies, product launches, and other latest Insulin Delivery Devices market developments are included in the research work.

Scope of the Insulin Delivery Devices report
This report covers the 2018 market scenario and outlook of Insulin Delivery Devices to 2025. Market size is computed using different types, applications of Insulin Delivery Devices across geographies.

1. Insulin Delivery Devices market size, US$, 2018-2025
2. Insulin Delivery Devices market drivers
3. Insulin Delivery Devices market challenges
4. Insulin Delivery Devices market opportunities
5. Insulin Delivery Devices market trends
6. Insulin Delivery Devices market size forecast by type, 2018-2025
7. Insulin Delivery Devices market size forecast by application, 2018-2025
8. Insulin Delivery Devices market size forecast by country, 2018-2025
9. Insulin Delivery Devices market companies and their strategies
10. Financial and Business Profile of leading vendors
11. Insulin Delivery Devices market news and deals

The unbiased independent analysis can save clients significant time and expense by providing an intensive evaluation of Insulin Delivery Devices market conditions. Our intensive research and sophisticated forecast methodology ensure the reliability of market estimates. Further, one free hour of our analyst’s time can be provided upon the procurement of this market report.

The report will be delivered in two working days after order confirmation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd.
  • Eli Lilly
  • F. Hoffmann-La Roche Ltd.
  • Insulet

1. Table of Contents
1.1. List of Tables
1.2. List of Figures
2. A Review of 2018. and Outlook to 2025
2.1. Trend Analysis
2.2. Critical Success Factors
2.3. Demand and Growth Dynamics by Type
2.4. Demand and Growth Dynamics by Application
2.5. Demand and Growth Dynamics by Market
3. Strategic Analysis
3.1. Largest Drivers of Insulin Delivery Devices Market Growth
3.2. Different Challenges Faced by Insulin Delivery Devices Companies
3.3. Five Forces Analysis
4. Global Insulin Delivery Devices Market Outlook by Product
4.1 Insulin syringes
4.2 Insulin pens
4.3 Insulin pumps
4.4 Insulin injectors
5. Global Insulin Delivery Devices Market Outlook by End-Use
5.1 Hospital
5.2 Homecare
5.3 Others
6 Asia Pacific Insulin Delivery Devices Market Outlook
6.1 Leading Insulin Delivery Devices Types contributing to Asia Pacific market
6.2 Top Applications contributing to Asia Pacific Insulin Delivery Devices
6.3 Top countries contributing to Asia Pacific Insulin Delivery Devices
7. Europe Insulin Delivery Devices Market Outlook
7.1 Leading Insulin Delivery Devices Types contributing to Europe market
7.2 Top Applications contributing to Europe Insulin Delivery Devices
7.3 Top countries contributing to Europe Insulin Delivery Devices
8. North America Insulin Delivery Devices Market Outlook
8.1 Leading Insulin Delivery Devices Types contributing to North America market
8.2 Top Applications contributing to North America Insulin Delivery Devices
8.3 Top countries contributing to North America Insulin Delivery Devices
9. South and Central America Insulin Delivery Devices Market Outlook
9.1 Leading Insulin Delivery Devices Types contributing to South and Central America market
9.2 Top Applications contributing to South and Central America Insulin Delivery Devices
9.3 Top countries contributing to South and Central America Insulin Delivery Devices
10 Middle East Africa Insulin Delivery Devices Market Outlook
10.1 Leading Insulin Delivery Devices Types contributing to Middle East Africa market
10.2 Top Applications contributing to Middle East Africa Insulin Delivery Devices
10.3 Top countries contributing to Middle East Africa Insulin Delivery Devices
11 Company Profile Snapshots
11.1 Top Companies Operating in Insulin Delivery Devices market
11.2 Abbott Laboratories Business Profile, SWOT and Financial Analysis
11.3 Becton Dickinson Business Profile, SWOT and Financial Analysis
11.4 Biocon Ltd. Business Profile, SWOT and Financial Analysis
11.5 Eli Lilly Business Profile, SWOT and Financial Analysis
11.6 F. Hoffmann-La Roche, Ltd. Business Profile, SWOT and Financial Analysis
11.7. Insulet Business Profile, SWOT and Financial Analysis
11.8. Medtronic Business Profile, SWOT and Financial Analysis
11.9. Novo Nordisk Business Profile, SWOT and Financial Analysis
11.10 Sanofi Business Profile, SWOT and Financial Analysis
11.11 Wockhardt Ltd. Business Profile, SWOT and Financial Analysis
12 Recent Industry Developments
13 Appendix
13.1 Author's Expertise
13.2 Sources and Methodology
13.3 Contacts
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd.
  • Eli Lilly
  • F. Hoffmann-La Roche Ltd.
  • Insulet
  • Medtronic
  • Novo Nordisk
  • Sanofi
  • Wockhardt Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...